AcelRx is dedicated to the development and commercialization of new therapies for the treatment of pain and other conditions where there is an unmet need for improved safety and efficacy. It aims to improve the quality of medical care by bringing novel technologies to market that meet the needs of patients, physicians, regulators and payers.

The company applies its proprietary dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of currently approved compounds.